Correction: Chemoprevention of malaria with long-acting oral and injectable drugs: an updated target product profile
Malar J
.
2024 Nov 29;23(1):363.
doi: 10.1186/s12936-024-05186-5.
Authors
Myriam El Gaaloul
1
,
Andre Marie Tchouatieu
2
,
Kassoum Kayentao
3
,
Brice Campo
4
,
Benedicte Buffet
4
,
Hanu Ramachandruni
4
,
Jean Louis Ndiaye
5
,
Timothy N C Wells
4
,
Celine Audibert
4
,
Jane Achan
6
,
Cristina Donini
4
,
Hellen C Barsosio
7
8
,
Halidou Tinto
9
Affiliations
1
MMV Medicines for Malaria Venture, Route de Pré‑Bois 20, Post Box 1826, 1215, Geneva 15, Switzerland.
[email protected]
.
2
MMV Medicines for Malaria Venture, Route de Pré‑Bois 20, Post Box 1826, 1215, Geneva 15, Switzerland.
[email protected]
.
3
Malaria Research and Training Center, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali.
4
MMV Medicines for Malaria Venture, Route de Pré‑Bois 20, Post Box 1826, 1215, Geneva 15, Switzerland.
5
University Iba Der Thiam of Thiès, Thiès, Senegal.
6
Malaria Consortium, London, UK.
7
Kenya Medical Research Institute, Centre for Global Health Research, Kisumu, Kenya.
8
Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, UK.
9
Clinical Research Unit of Nanoro, Institut de Recherche en Sciences de la Santé, Nanoro, Burkina Faso.
PMID:
39614327
PMCID:
PMC11605851
DOI:
10.1186/s12936-024-05186-5
No abstract available
Publication types
Published Erratum